Beta Drugs Ltd share price logo

Beta Drugs Ltd Share Price

NSE: BETA

BSE: 535022

Small Cap

Healthcare Sector

₹1816.60

-38.40

(-2.07%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Beta Drugs Ltd Stock Performance

as on November 3, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,804.8
    ₹1,850
    downward going graph

    0.65%

    Downside

    1.84%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,429.52
    ₹2,215.24
    downward going graph

    21.31%

    Downside

    21.94%

    Upside

    downward going graph

Beta Drugs Ltd share price movements today

Previous Close
₹1,855.00
Open
₹1,840.00
Volume
1,995.00
Upper Circuit
₹2,226.00
Lower Circuit
₹1,484.00
Day's Low - High
₹1,804.8 - ₹1,850
52 Week Low - High
₹1,429.52 - ₹2,215.24

Beta Drugs Ltd Historical Returns

1 Month Return
+ 1.82 %
3 Month Return
+ 6.24 %
1 Year Return
-3.73 %
3 Year Return
+ 159.87 %
5 Year Return
+ 1558.69 %

Beta Drugs Ltd Fundamentals

as on November 3, 2025 at 4:01 pm IST

Market Cap

₹1,833.78 Cr

Return on Equity (ROE)

15.3

PE Ratio (TTM)

0

Return on capital employed (ROCE)

15.57

Beta (LTM)

1.12

P/B Ratio

14.91

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

0

EPS (TTM)

42.02

Sector

Pharmaceuticals

Book Value

195.25

Technical Analysis

Bullish

View Technical Analysis

Beta Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Beta Drugs Ltd image
Beta Drugs Ltd
NA1,833.78311.74%0.7142362
Windlas Biotech Ltd image
Windlas Biotech Ltd
NA2,020.1527.08%0.5360759
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY28,419.0025.06%0.682641,197
Kimia Biosciences Ltd image
Kimia Biosciences Ltd
NA150.64-1.46%0.009118
Vilin Bio Med Ltd image
Vilin Bio Med Ltd
NA35.29-2.25%0.00114
See all

Beta Drugs Ltd Stock’s Investor Sentiment and Interest

Search interest for Beta Drugs Ltd Stock has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:64% versus previous 30 day period

Beta Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
65.93
90.81
116.12
183.84
227.11
295.71
362.36
Other Income
0.37
0.41
0.5
0.76
0.75
1.36
6.44
Total Income
66.3
91.22
116.62
184.59
227.87
297.07
368.79
Expenses
54.12
72.9
91.38
141.14
173.99
235.72
292.32
Operating Profit
11.81
17.91
24.74
42.7
53.12
59.99
70.04
Operating Profit Margin %
17.91%
19.72%
21.31%
23.23%
23.39%
20.29%
19.33%
Profit Before Interest, Tax and Depreciation
12.18
18.32
25.24
43.45
53.88
61.36
76.47
Interest
1.43
2.59
2.42
1.9
2.41
2.82
6.99
Depreciation
2.84
3.76
6.87
7.25
10.41
9.78
12.51
Profit Before Tax
7.91
11.97
15.95
34.3
41.06
48.76
56.97
Tax Paid
-0.13
2.56
4.23
9.48
10.34
12.32
14.55
Profit After Tax
8.04
9.42
11.72
24.83
30.72
36.44
42.42
Total Net profit including share of profit / Loss from associate company
8.04
9.42
11.72
24.83
30.72
36.44
42.42
EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02
Actual EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02
Adjusted EPS
8.86
9.46
11.62
24.59
30.43
36.1
42.02
Diluted EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02

Beta Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.1
0.11
8.41
18.6
29.63
23.38
30.93
36.14
Cash Flow from Investing Activities
-10.79
-20.78
-15.06
-5.86
-21.76
-19.07
-13.98
-35.72
Cash Flow from Financing Activities
5.45
12.07
8.72
-7.72
-0.98
-2.47
-7.49
117.97
Net Cash Flow
11.76
-8.61
2.09
5.04
6.9
1.84
9.47
118.39

Beta Drugs Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Nov 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
66.71%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
DII
0%
0%
0%
0%
0.02%
0%
0%
0%
0%
0%
0%
0%
FII
0%
0%
0%
0%
0.32%
0%
0%
0%
0%
0%
0%
0%
Public
32.96%
32.94%
32.94%
32.93%
32.92%
32.88%
32.25%
31.95%
31.94%
31.95%
32.2%
32.11%
Total Outstanding Shares
96,13,790
96,13,790
96,13,790
96,13,790
96,13,790
96,13,790
96,13,790
96,13,790
96,13,860
96,13,860
1,00,94,553
1,00,94,553
Total Shareholders
1,444
1,424
1,451
1,722
1,928
2,116
2,323
2,567
2,793
2,882
3,054
3,139

Insights on Beta Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BETA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, BETA stock has moved up by 8.5%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.90% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.73% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 14.2% return, outperforming this stock by 15.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 32.20% to 32.11% in Jun 2025 quarter

About Beta Drugs Ltd

Beta Drugs Limited is a part of the Adley Group, established in 1985 by its promoter Vijay Batra. It is a pharmaceutical formulation manufacturing company that produces and markets drugs to domestic and international customers. The Company specializes in the production of oncology products such as anticancer tablets, capsules, injections and lyophilized injections. With a portfolio of over 50 products catering to various oncology diseases such as breast cancer, brain cancer, bone cancer, lung cancer, mouth cancer, head and neck cancer, prostate cancer, haematology and cervics oeaophagus, Beta Drugs is an important contributor to the healthcare industry. The Company was originally incorporated in Himachal Pradesh in 2005 as a private limited company and was converted into a public limited company in 2017. Under the charge of Vijay Batra, Beta Drugs has become a well-recognized and trusted international healthcare brand.

Listing date: 12 Oct, 2017
Chairperson Name: Rahul Batra
OrganisationBeta Drugs Ltd
IndustryPharmaceuticals
CEORahul Batra
E-voting on sharesClick here to vote

FAQs

What is Beta Drugs Ltd share price today?

Beta Drugs Ltd share price today stands at ₹1816.6 as on at the close of the market. Beta Drugs Ltd share today touched a day high of ₹1850 and a low of ₹1804.8.

What is the 52 week high and 52 week low range for Beta Drugs Ltd share?

Beta Drugs Ltd touched a 52 week high of ₹2215.24 and a 52 week low of ₹1429.52. Beta Drugs Ltd share price today i.e. is closed at ₹1816.6, which is -18.00% down from its 52 week high and 27.08% up from its 52 week low.

What is Beta Drugs Ltd's market capitalisation today?

Beta Drugs Ltd market capitalisation is ₹1,833.78 Cr as on .

How to buy Beta Drugs Ltd shares?

To buy Beta Drugs Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BETA or Beta Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Beta Drugs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Beta Drugs Ltd trading volume today?

Beta Drugs Ltd trading volume is 1,995.00 as on . This means that 1,995.00 shares of Beta Drugs Ltd were bought and sold on the stock market during today's trading session.